sk pharmteco

Green chemistry concept

The Principles of Green Chemistry – Second Principle: Atom Economy

Blog / By

Our latest blog series is designed to guide readers towards a greener, more sustainable laboratory. Each entry explores one principle. If you missed our previous principles, they are all posted on our blog page, which can be found here. Second Principle: Atom Economy This principle states, “Synthetic methods should be designed to maximize incorporation of all […]

The Principles of Green Chemistry – Second Principle: Atom Economy Read More »

SK pharmteco and AaviGen Announce Strategic Partnership to Manufacture AaviGen’s Lead Gene Therapy Product for Heart Failure

News / By

FOR IMMEDIATE RELEASE  PARIS, France and HEIDELBERG, Germany (October 2, 2024) – SK pharmteco, a global contract development and manufacturing organization (CDMO) for small molecules and advanced therapies, and AaviGen GmbH, a preclinical stage biotechnology company focused on the development of curative gene therapies for cardiovascular and cardiopulmonary diseases, today announced a multi-year manufacturing agreement

SK pharmteco and AaviGen Announce Strategic Partnership to Manufacture AaviGen’s Lead Gene Therapy Product for Heart Failure Read More »

SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production

News / By

FOR IMMEDIATE RELEASE  Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong  More than 300 new employees to be hired for the anticipated 2026 opening  RANCHO CORDOVA, Ca. (September 30, 2024) – SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a major expansion of its small molecule and

SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production Read More »

SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices

News / By

      NASHVILLE, Tenn., and RANCHO CORDOVA, Ca. – September 25, 2024 – Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport”), a global leader in supply  chain solutions for the life sciences industry, and SK pharmteco, a global contract development and manufacturing organization, today announced a strategic collaboration to provide fully integrated logistics and manufacturing services to biotechnology

SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices Read More »

Partnering through Membership – Part One: EFCG Membership Assures Supplies of Affordable Medicines to Patients

Blog / By

The pharmaceutical industry has valuable organizations and advocacy groups that work for the benefit of its members and, in turn, for patients. We are beginning an occasional series that offers insight into some of these organizations, along with the aims of each. For our first entry, we examine the European Fine Chemicals Group (EFCG) and

Partnering through Membership – Part One: EFCG Membership Assures Supplies of Affordable Medicines to Patients Read More »

Green chemistry concept

The Principles of Green Chemistry – First Principle: Prevent Waste 

Blog / By

Our latest blog series is designed to guide readers towards a greener, more sustainable laboratory [environment]. In 1998, Paul Anastas and John Warner defined the 12 principles of Green Chemistry in their book, Green Chemistry: Theory and Practice.1 Yale Professor Paul Anastas, also known as the “father of Green Chemistry,” defined the specific tenets required to

The Principles of Green Chemistry – First Principle: Prevent Waste  Read More »

SK pharmteco Appoints Patrick Mahieux as President of Cell and Gene, Europe 

News / By

FOR IMMEDIATE RELEASE  RANCHO CORDOVA, Ca. (August 27, 2024) – SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced the appointment of Patrick Mahieux as President of Cell and Gene, Europe. Based in Paris at Yposkesi, an SK pharmteco company, Mahieux will lead the company’s cell and gene therapy business across the

SK pharmteco Appoints Patrick Mahieux as President of Cell and Gene, Europe  Read More »

SK pharmteco’s Swords Facility Celebrates 60 Years of Pharmaceutical Excellence

News / By

Swords, Ireland – [August 26, 2024] – SK pharmteco’s Swords facility celebrated its 60th anniversary on August 8th, marking six decades of pharmaceutical manufacturing excellence. Since its establishment in 1964, the facility has grown into a global leader in the development and production of critical active pharmaceutical ingredients (APIs).  “It is an honor to commemorate

SK pharmteco’s Swords Facility Celebrates 60 Years of Pharmaceutical Excellence Read More »

2025 and Beyond: A Look at Upcoming NDSRI Regulations 

Blog / By

The presence of nitrosamine drug substance-related impurities (NDSRIs) in medications has become an urgent issue for the pharmaceutical industry.  In response, the FDA issued critical new guidance in August 2023, setting strict acceptable intake limits (AIs) for NDSRIs. While some deadlines have already lapsed, an imminent deadline looms: August 1, 2025. By this date, manufacturers

2025 and Beyond: A Look at Upcoming NDSRI Regulations  Read More »

SK pharmteco and Rznomics Explore Collaboration for RNA-based Gene Therapy Development and Manufacturing

News / By

SEONGNAM, South Korea, Aug. 5, 2024 – SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving both the small molecule and cell & gene therapy industry, and Rznomics Inc., a South Korea-based biopharmaceutical company specializing in the development of RNA-based gene therapeutics, have signed a memorandum of understanding (MOU) for a contract

SK pharmteco and Rznomics Explore Collaboration for RNA-based Gene Therapy Development and Manufacturing Read More »

Links
Compliance
Twitter Linkedin-in Facebook-square
Copyright ©2024 by SK pharmteco Inc. All Rights Reserved
Scroll to Top

Enter your details to access Marketing Materials

"*" indicates required fields